Healthline
November 14, 2025
Share on PinterestThe TrumpRx prescription drug savings program is expected to be available by early 2026. Eli Lilly and Novo Nordisk have agreed to sell their […]
November 12, 2025
Share on PinterestThe FDA will remove black box warning labels on HRT products, which the agency states has sown confusion around hormone therapy for menopause. Lupe […]
November 12, 2025
Share on PinterestAcetaminophen is the safest option for pain relief and lowering fever during pregnancy. Anfisa&friends/Stocksy A new research review disputes claims made by the Trump […]
November 11, 2025
Share on PinterestA new clinical trial found that coffee drinkers with AFib had a significantly lower risk of recurrence. Boy_Anupong/Getty Images A new clinical trial challenges […]
Medscape
July 3, 2025
TOPLINE: In a network meta-analysis of 25 randomized trials, sonelokimab was ranked highest for treating patients with moderate-to-severe hidradenitis suppurativa (HS). Adalimumab, lutikizumab, and bimekizumab were […]
July 2, 2025
The FDA has granted accelerated approval to linvoseltamab (Lynozyfic, Regeneron) for relapsed or refractory multiple myeloma (MM) after at least four prior lines of therapy, including […]
July 2, 2025
The number of live births in England and Wales rose last year, the first increase since 2021, according to the Office for National Statistics (ONS). There were […]
July 2, 2025
For nearly 15 years, Donald Edmondson, PhD, executive director of the Center for Behavioral Cardiovascular Health at Columbia University Irving Medical Center in New York City, […]
FDA
December 19, 2025
[December 19, 2025] The U.S. Food and Drug Administration (FDA) today qualified total hip bone mineral density (BMD) as assessed by dual energy X-ray absorptiometry (DXA) […]
December 19, 2025
Bavencio (avelumab) Imfinzi (durvalumab) Tecentriq (atezolizumab) Yervoy (ipilimumab) Cardiac failure FDA decided that no action is necessary at this time based on available information. Invega Sustenna […]
December 18, 2025
Issued by: Guidance Issuing Office Office of the Commissioner, Office of Clinical Policy and Programs, Office of Clinical Policy, Office of Good Clinical Practice This guidance […]
December 18, 2025
Issued by: Guidance Issuing Office Office of the Commissioner, Office of Clinical Policy and Programs, Office of Clinical Policy, Office of Good Clinical Practice This guidance […]
